Back
NovoCure Vs. Perspective Therapeutics Industry Stock Comparison
Sell
43
NVCR
NovoCure
Last Price:
14.18
Seasonality Move:
6.82%
Buy
81
CATX
Perspective Therapeutics
Last Price:
1.74
Seasonality Move:
1.64%
Sell
43
NovoCure (NVCR)
is a Sell
Is NovoCure a Buy, Sell or Hold?
- The current NovoCure [NVCR] share price is $14.19. The Score for NVCR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
81
Perspective Therapeutics (CATX)
is a Buy
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $1.73. The Score for CATX is 81, which is 62% above its historic median score of 50, and infers lower risk than normal.
- CATX is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $1.73
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 57.95 | Buy |
Chaikin Money Flow: | 1387557 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.19 - 14.51) | Buy |
Bollinger Bands (100): | (12.92 - 15.46) | Sell |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 68.06 | Buy |
Chaikin Money Flow: | -5156296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.39 - 1.65) | Buy |
Bollinger Bands (100): | (0.51 - 1.37) | Buy |
NVCR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 12.65 | Buy |
20-day SMA: | 12.98 | Buy |
50-day SMA: | 14.2 | Sell |
200-day SMA: | 17.13 | Sell |
8-day EMA: | 12.89 | Buy |
20-day EMA: | 13.04 | Buy |
50-day EMA: | 13.72 | Buy |
200-day EMA: | 22.25 | Sell |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.67 | Buy |
20-day SMA: | 1.56 | Buy |
50-day SMA: | 1.3 | Buy |
200-day SMA: | 0.64 | Buy |
8-day EMA: | 1.65 | Buy |
20-day EMA: | 1.55 | Buy |
50-day EMA: | 1.32 | Buy |
200-day EMA: | 0.81 | Buy |
NovoCure Earnings Growth & NVCR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.63 per share, and a decrease next year of $0.41 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovoCure Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |